The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Self-citation(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.018 · Cited by 1,318
Self-citationRegillo, C. D., Brown, D. M., Abraham, P., Yue, H., Ianchulev, T., Schneider, S., & Shams, N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.10.004 · Cited by 858
Self-citationRanibizumab for Macular Edema following Branch Retinal Vein Occlusion
Campochiaro, P. A., Heier, J. S., Feiner, L., Gray, S., Saroj, N., Rundle, A. C., Murahashi, W. Y., & Rubio, R. G. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.021 · Cited by 818
Self-citationThe SCORE Study Research Group* (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.233 · Cited by 458
Abraham, P., Yue, H., & Wilson, L. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.04.011 · Cited by 441
Cited by
Molecular pathogenesis of retinal and choroidal vascular diseases
Campochiaro, P. A. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.002 · Cited by 545
Self-citationRanibizumab for Macular Edema Due to Retinal Vein Occlusions
Heier, J. S., Campochiaro, P. A., Yau, L., Li, Z., Saroj, N., Rubio, R. G., & Lai, P. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.005 · Cited by 470
Self-citationIntravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
Campochiaro, P. A., Clark, W. L., Boyer, D. S., Heier, J. S., Brown, D. M., Vitti, R., Kazmi, H., Berliner, A. J., Erickson, K., Chu, K. W., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.08.031 · Cited by 385
Self-citationLong-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab
Campochiaro, P. A., Sophie, R., Pearlman, J., Brown, D. M., Boyer, D. S., Heier, J. S., Marcus, D. M., Feiner, L., & Patel, A. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.038 · Cited by 351
Self-citationThree-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
Schmidt-Erfurth, U., Lang, G. E., Holz, F. G., Schlingemann, R. O., Lanzetta, P., Massin, P., Gerstner, O., Bouazza, A. S., Shen, H., Osborne, A., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.041 · Cited by 325
Metadata
- Authors
- Brown, D. M., Campochiaro, P. A., Bhisitkul, R. B., Ho, A. C., Gray, S., Saroj, N., Adamis, A. P., Rubio, R. G., & Murahashi, W. Y.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 118
- Issue
- 8
- Pages
- 1594-1602
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W4237391818
- Cited by
- 465
- References
- 7
- FWCI
- 28.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.